XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Preferred Stock
Common Stock
Additional Paid-In Capital
  Retained Earnings
  Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive (Loss) Income
Treasury Stock
Shares of Preferred Stock Outstanding, beginning balance (in shares) at Dec. 31, 2022     445            
Beginning balance at Dec. 31, 2022 $ 266,034 $ (2,102) $ 445 $ 1,223 $ 136,201 $ 131,706 $ (2,102) $ (526) $ (3,015)
Shares of Common Stock issued, beginning balance (in shares) at Dec. 31, 2022       12,225,097          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 11,130         11,130      
Common stock options exercised (in shares)       6,096          
Common stock options exercised 33       33        
Other comprehensive income (loss) 61             61  
Stock compensation expense 107       107        
Dividend on preferred stock (7)         (7)      
Dividend on common stock (2,150)         (2,150)      
Shares of Preferred Stock Outstanding, ending balance (in shares) at Mar. 31, 2023     445            
Ending balance at Mar. 31, 2023 $ 273,106   $ 445 $ 1,223 136,341 138,577   (465) (3,015)
Shares of Common Stock issued, ending balance (in shares) at Mar. 31, 2023       12,231,193          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Accounting Standards Update [Extensible List] Accounting Standards Update 2016-13                
Shares of Preferred Stock Outstanding, beginning balance (in shares) at Dec. 31, 2023 375   375            
Beginning balance at Dec. 31, 2023 $ 284,317   $ 375 $ 1,224 136,700 149,437   (404) (3,015)
Shares of Common Stock issued, beginning balance (in shares) at Dec. 31, 2023       12,240,821          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 6,151         6,151      
Common stock options exercised (in shares)       6,522          
Common stock options exercised 56     $ 1 55        
Other comprehensive income (loss) (26)             (26)  
Stock compensation expense 46       46        
Dividend on preferred stock (6)         (6)      
Dividend on common stock $ (2,152)         (2,152)      
Shares of Preferred Stock Outstanding, ending balance (in shares) at Mar. 31, 2024 375   375            
Ending balance at Mar. 31, 2024 $ 288,386   $ 375 $ 1,225 $ 136,801 $ 153,430   $ (430) $ (3,015)
Shares of Common Stock issued, ending balance (in shares) at Mar. 31, 2024       12,247,343